Study ID: NRG CC004
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer
This is a trial of bupropion versus placebo for sexual desire in women with breast or gynecological cancers. The trial will be measuring the ability of two dose levels of bupropion to improve sexual desire more than a placebo at 9 weeks.
Bismarck Region, Fargo Region, Sioux Falls Region
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Cancer Control, Breast - Invasive, Endometrial, Gynecologic, Other, Ovary/Fallopian Tube/Primary Peritoneal, Vulvar, Cervix
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.